Esophageal Cancer Market Overview
Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. Esophageal cancer is cancer arising from the esophagus which is the food pipe connecting the throat and the stomach. Symptoms of esophageal cancer include difficulty and in swallowing which causes reduced food intake and weight loss, enlarged lymph nodes, cough which includes blood etc. The two main sub-types of esophageal cancer are esophageal squamous-cell carcinoma which arises from the epithelial cells and esophageal adenocarcinoma which arises from the glandular cells. These two cancers have different primary causes and different rates of prevalence. Esophageal squamous-cell carcinoma is more common in the developing world, and esophageal adenocarcinoma is more common in the developed world. Causes of the squamous-cell carcinoma include tobacco, alcohol, very hot drinks, poor diet, and chewing betel nut while the most common causes of the adenocarcinoma are smoking tobacco, obesity, and acid reflux.
Considering all these factors the esophageal cancer treatment market is expected to reach $ 1000.1 million by the end of 2023, this market is projected to growing at a CAGR of 0.087 % during 2017-2023.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/3280
Esophageal Cancer Market Segmentation
The global esophageal cancer treatment market is segmented on the basis of type. Based on the type, the market has been segmented as esophageal squamous-cell carcinoma, esophageal adenocarcinoma and others. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the treatment, the market has been segmented as surgery, chemotherapy and radiotherapy and other.
Esophageal Cancer Market Regional Analysis
US accounts for the maximum esophageal cancer treatment market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.
Esophageal Cancer Market Players
- Globus Medical, Inc. (U.S.)
- Depuy Synthes Inc. (Johnson Johnson) (U.S.)
- Smith Nephew plc. (UK)
- NuVasive, Inc. (U.S.)
- Stryker Corporation (U.S.)
- Integra LifeSciences Holdings Corporation (U.S.)
- Zimmer Biomet Holdings, Inc. (U.S.)
- Medtronic, plc (Ireland)
- Wright Medical Group N.V. (Netherlands)
- The Orthopedic Implant Company (U.S.)
- Aesculap Implant Systems (U.S.)
- Conmed Corporation (U.S.)
- BioTek Instruments, Inc. (U.S.)
- Arthrocare Corporation (U.S.)
among others are some key companies in the global esophageal cancer that are listed by MRFR for market research.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
